{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:38Z","timestamp":1793900558793,"version":"4.8.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T00:00:00Z","timestamp":1358294400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>S100A12 protein is an endogenous receptor ligand for advanced glycation end products. In this study, the plasma S100A12 level was assessed as an independent predictor of mortality, and its utility in clinical settings was examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In a previous cross-sectional study, plasma S100A12 levels were measured in 550 maintenance hemodialysis patients to determine the association between S100A12 and the prevalence of cardiovascular diseases (CVD). In this prospective study, the risk of mortality within a two-year period was determined. An integer scoring system was developed to predict mortality on the basis of the plasma S100A12 levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Higher plasma S100A12 levels (\u226518.79 ng\/mL) were more closely associated with higher all-cause mortality than lower plasma S100A12 levels (&lt;18.79 ng\/mL; <jats:italic>P<\/jats:italic> = 0.001). Multivariate Cox proportional hazards analysis revealed higher plasma S100A12 levels [hazard ratio (HR), 2.267; 95% confidence interval (CI), 1.195\u20134.302; <jats:italic>P<\/jats:italic> = 0.012], age \u226565 years (HR, 1.961; 95%CI, 1.017\u20133.781; <jats:italic>P<\/jats:italic> = 0.044), serum albumin levels &lt;3.5 g\/dL (HR, 2.198; 95%CI, 1.218\u20133.968; <jats:italic>P<\/jats:italic> = 0.012), and history of CVD (HR, 2.068; 95%CI, 1.146\u20133.732; <jats:italic>P<\/jats:italic> = 0.016) to be independent predictors of two-year all-cause mortality. The integer score was derived by assigning points to these factors and determining total scores. The scoring system revealed trends across increasing scores for predicting the all-cause mortality [c-statistic = 0.730 (0.656\u20130.804)]. The resulting model demonstrated good discriminative power for distinguishing the validation population of 303 hemodialysis patients [c-statistic = 0.721 (0.627\u20130.815)].<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The results indicate that plasma S100A12 level is an independent predictor for two-year all-cause mortality. A simple integer scoring system was therefore established for predicting mortality on the basis of plasma S100A12 levels.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2369-14-16","type":"journal-article","created":{"date-parts":[[2013,1,16]],"date-time":"2013-01-16T23:14:26Z","timestamp":1358378066000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan"],"prefix":"10.1186","volume":"14","author":[{"given":"Yayoi","family":"Shiotsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukiyo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuguru","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Imada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noboru","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiko","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Tamagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kosaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,16]]},"reference":[{"key":"427_CR1","first-page":"88","volume":"6","author":"BH Scribner","year":"1960","unstructured":"Scribner BH, Caner JE, Buri R, Quinton W: The tecnique of continuous hemodialysis. Trans Am Soc Artif Intern Organs. 1960, 6: 88-103.","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"427_CR2","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1056\/NEJMra0902710","volume":"363","author":"J Himmelfarb","year":"2010","unstructured":"Himmelfarb J, Ikizler TA: Hemodialysis. N Engl J Med. 2010, 363: 1833-1845. 10.1056\/NEJMra0902710.","journal-title":"N Engl J Med"},{"key":"427_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1744-9987.2011.01050.x","volume":"16","author":"S Nakai","year":"2012","unstructured":"Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, Shigematsu T, Shinoda T, Shoji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Masakane I, Marubayashi S, Morita O, Yamagata K, Wakai K, Wada A, Watanabe Y, Tsubakihara Y: Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial. 2012, 16: 11-53. 10.1111\/j.1744-9987.2011.01050.x.","journal-title":"Ther Apher Dial"},{"key":"427_CR4","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1111\/j.1525-139X.2009.00659.x","volume":"22","author":"J Himmelfarb","year":"2009","unstructured":"Himmelfarb J: Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial. 2009, 22: 636-643. 10.1111\/j.1525-139X.2009.00659.x.","journal-title":"Semin Dial"},{"key":"427_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/j.1744-9987.2007.00523.x","volume":"11","author":"S Nakai","year":"2007","unstructured":"Nakai S, Masakane I, Akiba T, Iseki K, Watanabe Y, Itami N, Kimata N, Shigematsu T, Shinoda T, Syoji T, Syoji T, Suzuki K, Tsuchida K, Nakamoto H, Hamano T, Marubayashi S, Morita O, Morozumi K, Yamagata K, Yamashita A, Wakai K, Wada A, Tsubakihara Y: Overview of regular dialysis treatment in Japan (as of 31 December 2005). Ther Apher Dial. 2007, 11: 411-441. 10.1111\/j.1744-9987.2007.00523.x.","journal-title":"Ther Apher Dial"},{"key":"427_CR6","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1681\/ASN.2004080635","volume":"16","author":"S Agalou","year":"2005","unstructured":"Agalou S, Ahmed N, Babaei-Jadidi R, Dawnay A, Thornalley PJ: Profound mishandling of protein glycation degradation products in uremia and dialysis. J Am Soc Nephrol. 2005, 16: 1471-1485. 10.1681\/ASN.2004080635.","journal-title":"J Am Soc Nephrol"},{"key":"427_CR7","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1097\/01.ASN.0000131526.99506.F7","volume":"15","author":"FF Hou","year":"2004","unstructured":"Hou FF, Ren H, Owen WF, Guo ZJ, Chen PY, Schmidt AM, Miyata T, Zhang X: Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. J Am Soc Nephrol. 2004, 15: 1889-1896. 10.1097\/01.ASN.0000131526.99506.F7.","journal-title":"J Am Soc Nephrol"},{"key":"427_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1479-5876-7-17","volume":"7","author":"LJ Sparvero","year":"2009","unstructured":"Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT: RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. J Transl Med. 2009, 7: 17-10.1186\/1479-5876-7-17.","journal-title":"J Transl Med"},{"key":"427_CR9","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0092-8674(00)80801-6","volume":"97","author":"MA Hofmann","year":"1999","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P, Neurath MF, Slattery T, Beach D, McClary J, Nagashima M, Morser J, Stern D, Schmidt AM: RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell. 1999, 97: 889-901. 10.1016\/S0092-8674(00)80801-6.","journal-title":"Cell"},{"key":"427_CR10","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/S1357-2725(01)00046-2","volume":"33","author":"R Donato","year":"2001","unstructured":"Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001, 33: 637-668. 10.1016\/S1357-2725(01)00046-2.","journal-title":"Int J Biochem Cell Biol"},{"key":"427_CR11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.2215\/CJN.08310910","volume":"6","author":"Y Shiotsu","year":"2011","unstructured":"Shiotsu Y, Mori Y, Nishimura M, Sakoda C, Tokoro T, Hatta T, Maki N, Iida K, Iwamoto N, Ono T, Matsuoka E, Kishimoto N, Tamagaki K, Matsubara H, Kosaki A: Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin J Am Soc Nephrol. 2011, 6: 718-723. 10.2215\/CJN.08310910.","journal-title":"Clin J Am Soc Nephrol"},{"key":"427_CR12","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000148646","volume":"29","author":"Y Mori","year":"2009","unstructured":"Mori Y, Kosaki A, Kishimoto N, Kimura T, Iida K, Fukui M, Nakajima F, Nagahara M, Urakami M, Iwasaka T, Matsubara H: Increased plasma S100A12 (EN-RAGE) levels in hemodialysis patients with atherosclerosis. Am J Nephrol. 2009, 29: 18-24. 10.1159\/000148646.","journal-title":"Am J Nephrol"},{"key":"427_CR13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00726-008-0097-7","volume":"36","author":"J Pietzsch","year":"2009","unstructured":"Pietzsch J, Hoppmann S: Human S100A12: a novel key player in inflammation?. Amino Acids. 2009, 36: 381-389. 10.1007\/s00726-008-0097-7.","journal-title":"Amino Acids"},{"key":"427_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1593\/neo.09284","volume":"11","author":"G Srikrishna","year":"2009","unstructured":"Srikrishna G, Freeze HH: Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia. 2009, 11: 615-628.","journal-title":"Neoplasia"},{"key":"427_CR15","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1001\/jama.2009.1488","volume":"302","author":"DJ de Jager","year":"2009","unstructured":"de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA. 2009, 302: 1782-1789. 10.1001\/jama.2009.1488.","journal-title":"JAMA"},{"key":"427_CR16","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.2215\/CJN.03360410","volume":"5","author":"A Nakashima","year":"2010","unstructured":"Nakashima A, Carrero JJ, Qureshi AR, Miyamoto T, Anderstam B, Barany P, Heimburger O, Stenvinkel P, Lindholm B: Effect of circulating soluble receptor for advanced glycation end products (sRAGE) and the proinflammatory RAGE ligand (EN-RAGE, S100A12) on mortality in hemodialysis patients. Clin J Am Soc Nephrol. 2010, 5: 2213-2219. 10.2215\/CJN.03360410.","journal-title":"Clin J Am Soc Nephrol"},{"key":"427_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.clinbiochem.2012.02.014","volume":"45","author":"M Kalousova","year":"2012","unstructured":"Kalousova M, Kubena AA, Benakova H, Dusilova-Sulkova S, Tesar V, Zima T: EN-RAGE (extracellular newly identified receptor for advanced glycation end-products binding protein) and mortality of long-term hemodialysis patients: A prospective observational cohort study. Clin Biochem. 2012, 45: 556-560. 10.1016\/j.clinbiochem.2012.02.014.","journal-title":"Clin Biochem"},{"key":"427_CR18","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.2215\/CJN.10411011","volume":"7","author":"JR Berger","year":"2012","unstructured":"Berger JR, Hedayati SS: Renal replacement therapy in the elderly population. Clin J Am Soc Nephrol. 2012, 7: 1039-1046. 10.2215\/CJN.10411011.","journal-title":"Clin J Am Soc Nephrol"},{"key":"427_CR19","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11906-011-0223-x","volume":"13","author":"TI Chang","year":"2011","unstructured":"Chang TI: Systolic blood pressure and mortality in patients on hemodialysis. Curr Hypertens Rep. 2011, 13: 362-369. 10.1007\/s11906-011-0223-x.","journal-title":"Curr Hypertens Rep"},{"key":"427_CR20","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/j.1744-9987.2010.00836.x","volume":"14","author":"Y Tsubakihara","year":"2010","unstructured":"Tsubakihara Y, Nishi S, Akiba T, Hirakata H, Iseki K, Kubota M, Kuriyama S, Komatsu Y, Suzuki M, Nakai S, Hattori M, Babazono T, Hiramatsu M, Yamamoto H, Bessho M, Akizawa T: 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease. Ther Apher Dial. 2010, 14: 240-275. 10.1111\/j.1744-9987.2010.00836.x.","journal-title":"Ther Apher Dial"},{"key":"427_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003, 107: 499-511. 10.1161\/01.CIR.0000052939.59093.45.","journal-title":"Circulation"},{"key":"427_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1542-4758.2009.00377.x","volume":"13","author":"AA Desai","year":"2009","unstructured":"Desai AA, Nissenson A, Chertow GM, Farid M, Singh I, Van Oijen MG, Esrailian E, Solomon MD, Spiegel BM: The relationship between laboratory-based outcome measures and mortality in end-stage renal disease: a systematic review. Hemodial Int. 2009, 13: 347-359. 10.1111\/j.1542-4758.2009.00377.x.","journal-title":"Hemodial Int"},{"key":"427_CR23","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/j.1744-9987.2008.00648.x","volume":"12","author":"Guideline Working Group, Japanese Society for Dialysis Therapy","year":"2008","unstructured":"Guideline Working Group, Japanese Society for Dialysis Therapy: Clinical practice guideline for the management of secondary hyperparathyroidism in chronic dialysis patients. Ther Apher Dial. 2008, 12: 514-525.","journal-title":"Ther Apher Dial"},{"key":"427_CR24","first-page":"CD004289","volume":"3","author":"SD Navaneethan","year":"2009","unstructured":"Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GF: HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev. 2009, 3: CD004289-","journal-title":"Cochrane Database Syst Rev"},{"key":"427_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB: Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996, 15: 361-387. 10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4.","journal-title":"Stat Med"},{"key":"427_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","volume":"8","author":"CE Metz","year":"1978","unstructured":"Metz CE: Basic principles of ROC analysis. Semin Nucl Med. 1978, 8: 283-298. 10.1016\/S0001-2998(78)80014-2.","journal-title":"Semin Nucl Med"},{"key":"427_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1189\/jlb.0306164","volume":"81","author":"ME Bianchi","year":"2007","unstructured":"Bianchi ME: DAMPs, PAMPs and alarmins: all we need to know about danger. J Leukoc Biol. 2007, 81: 1-5.","journal-title":"J Leukoc Biol"},{"key":"427_CR28","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0140-6736(03)12986-8","volume":"361","author":"D Foell","year":"2003","unstructured":"Foell D, Ichida F, Vogl T, Yu X, Chen R, Miyawaki T, Sorg C, Roth J: S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet. 2003, 361: 1270-1272. 10.1016\/S0140-6736(03)12986-8.","journal-title":"Lancet"},{"key":"427_CR29","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/keg385","volume":"42","author":"D Foell","year":"2003","unstructured":"Foell D, Kane D, Bresnihan B, Vogl T, Nacken W, Sorg C, Fitzgerald O, Roth J: Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford). 2003, 42: 1383-1389. 10.1093\/rheumatology\/keg385.","journal-title":"Rheumatology (Oxford)"},{"key":"427_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1136\/gut.52.6.847","volume":"52","author":"D Foell","year":"2003","unstructured":"Foell D, Kucharzik T, Kraft M, Vogl T, Sorg C, Domschke W, Roth J: Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut. 2003, 52: 847-853. 10.1136\/gut.52.6.847.","journal-title":"Gut"},{"key":"427_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1161\/ATVBAHA.110.217745","volume":"31","author":"MA Hofmann Bowman","year":"2011","unstructured":"Hofmann Bowman MA, Gawdzik J, Bukhari U, Husain AN, Toth PT, Kim G, Earley J, McNally EM: S100A12 in vascular smooth muscle accelerates vascular calcification in apolipoprotein E-null mice by activating an osteogenic gene regulatory program. Arterioscler Thromb Vasc Biol. 2011, 31: 337-344. 10.1161\/ATVBAHA.110.217745.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"427_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","volume":"340","author":"R Ross","year":"1999","unstructured":"Ross R: Atherosclerosis\u2013an inflammatory disease. N Engl J Med. 1999, 340: 115-126. 10.1056\/NEJM199901143400207.","journal-title":"N Engl J Med"},{"key":"427_CR33","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s10754-007-9017-8","volume":"7","author":"S Fukuhara","year":"2007","unstructured":"Fukuhara S, Yamazaki C, Hayashino Y, Higashi T, Eichleay MA, Akiba T, Akizawa T, Saito A, Port FK, Kurokawa K: The organization and financing of end-stage renal disease treatment in Japan. Int J Health Care Finance Econ. 2007, 7: 217-231. 10.1007\/s10754-007-9017-8.","journal-title":"Int J Health Care Finance Econ"},{"key":"427_CR34","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1681\/ASN.2011111094","volume":"23","author":"R Vanholder","year":"2012","unstructured":"Vanholder R, Davenport A, Hannedouche T, Kooman J, Kribben A, Lameire N, Lonnemann G, Magner P, Mendelssohn D, Saggi SJ, Shaffer RN, Moe SM, Van Biesen W, van der Sande F, Mehrotra R: Reimbursement of dialysis: a comparison of seven countries. J Am Soc Nephrol. 2012, 23: 1291-1298. 10.1681\/ASN.2011111094.","journal-title":"J Am Soc Nephrol"},{"key":"427_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0272-6386(12)70363-3","volume":"15","author":"PJ Held","year":"1990","unstructured":"Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin DS: Five-year survival for end-stage renal disease patients in the United States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis. 1990, 15: 451-457.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-16\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-16.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T21:30:15Z","timestamp":1630531815000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,16]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["427"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-16","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,16]]},"assertion":[{"value":"16 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"16"}}